🏠 Work From Home Medical Writer Jobs | Syneos Health Hiring | Apply Now
📍 Location: Remote (India)
🎓 Eligibility: B.Pharm, M.Pharm, Pharm.D, MSc, BSc, Life Sciences
🧪 Experience: Minimum 1 Year
💰 Salary: Competitive | High CTC
📝 Job Type: Medical Writer I (CTT) | Full-Time | Clinical Research
🔎 Verified: ✅ Verified Job via Medical Jobs India – hitechplus.in
🏢 About Syneos Health
Syneos Health is a global leader in biopharmaceutical solutions, contributing to 94% of all novel FDA-approved drugs over the past 5 years. The Clinical Trial Transparency (CTT) team ensures compliance and accuracy in clinical trial disclosure and regulatory documentation.
📄 Job Overview
Syneos Health is hiring Medical Writer I (CTT) for remote work. The role involves preparing regulatory documents, clinical trial disclosures, and ensuring compliance with global regulations.
🔬 Key Responsibilities
- ✔ Write, edit, and review clinical/regulatory documents.
- ✔ Prepare study protocols, amendments, patient narratives, and investigator brochures.
- ✔ Ensure compliance with ICH-E3 and company SOPs.
- ✔ Collaborate with data management, biostatistics, and regulatory teams.
- ✔ Support protocol registration and results posting for regulatory authorities.
✅ Required Qualifications & Skills
- ✅ Minimum 1 year of experience in Clinical Trial Disclosure/Transparency.
- ✅ Strong knowledge of regulatory guidelines and clinical research processes.
- ✅ Excellent written and verbal communication skills.
- ✅ Ability to work in cross-functional global teams.
🎁 Benefits of Joining Syneos Health
- 🏠 100% Remote Work from Anywhere in India.
- 📈 Career growth in clinical research and medical writing.
- 🗂 Training programs and global exposure.
- 💼 Work with a company that has a strong impact on healthcare innovation.
📌 Note Before You Apply:
Highlight clinical trial disclosure, protocol registration, and results posting experience in your CV to increase shortlisting chances.
👇 Apply Link Will Be Visible in 15 Seconds 👇
🟢 Verified Job via Medical Jobs India – hitechplus.in
0 Comments